Hexagon Capital Partners LLC Corcept Therapeutics Inc Transaction History
Hexagon Capital Partners LLC
- $508 Million
- Q3 2024
A detailed history of Hexagon Capital Partners LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 598 shares of CORT stock, worth $32,471. This represents 0.01% of its overall portfolio holdings.
Number of Shares
598
Previous 598
-0.0%
Holding current value
$32,471
Previous $19,000
42.11%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
319Shares Held
88.1MCall Options Held
1.07MPut Options Held
822K-
Black Rock Inc. New York, NY16.5MShares$898 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.55MShares$519 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$447 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.91MShares$375 Million0.4% of portfolio
-
Parallel Advisors, LLC3.82MShares$207 Million3.2% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.82B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...